[1
]
University of Castilla-La Mancha, Talavera de la Reina, Toledo, Spain. julio.lopezbastida@uclm.es.
[2
]
Red de Investigación en Servicios Sanitarios en Enfermedades Crónicas (REDISSEC),
Madrid, Spain. julio.lopezbastida@uclm.es.
[3
]
Red de Investigación en Servicios Sanitarios en Enfermedades Crónicas (REDISSEC),
Madrid, Spain.
[4
]
Canary Islands Foundation for Health Research (FUNCANIS), Las Palmas de Gran Canaria,
Spain.
[5
]
University of Castilla-La Mancha, Toledo, Spain.
[6
]
Institute of Rare Diseases Research (IIER), Spain RDR and CIBERER, Madrid, Spain.
[7
]
Evaluation and Planning Service at Canary Islands Health Service, Santa Cruz de Tenerife,
Spain.
[8
]
London School of Economics and Political Science-Health Research Centre, London, UK.
[9
]
National Center for Rare Diseases, Istituto superiore di sanità (ISS), Rome, Italy.
[10
]
Centro di Ricerche Cliniche per Malattie Rare Aldo e Cele Daccò, Istituto di Ricerche
Farmacologiche Mario Negri, Ranica, Bergamo, Italy.
[11
]
Institute of Rare Diseases, Plovdiv, Bulgaria.
[12
]
Department of Social Medicine and Public Health, Faculty of Public Health, Medical
University of Plovdiv, Plovdiv, Bulgaria.
[13
]
Department of Health Economics, Corvinus University of Budapest, Budapest, Hungary.
[14
]
Federación Española de Enfermedades Raras (FEDER), Madrid, Spain.
[15
]
Centre for Health Economics/Institute for Risk and Insurance, Leibniz University,
Hannover, Germany.
[16
]
The Swedish Institute for Health Economics, Lund, Sweden.
[17
]
URC Eco Ile de France, AP-HP, Paris, France.
[18
]
Université Paris Diderot, Sorbonne Paris Cité, ECEVE, UMRS 1123, Paris, France.
[19
]
INSERM, ECEVE, U1123, Paris, France.
[20
]
Centre for Research on Health and Social Care (CERGAS), Bocconi University, Milan,
Italy.